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Abstract
Background: Cardiovascular risk factors contribute to morbidity and mortality among diabetic patients. National and 
international guidelines on management of diabetes therefore emphasize control to goals of blood glucose, blood pressure, 
dyslipidemia, and obesity so as to minimize the development of complications and enhance the patients’ quality of life.
Objective: To evaluate the status of control to goals of cardiometabolic risk factors among the diabetic patients attending 
the Diabetes clinic of University of Nigeria Teaching Hospital, Enugu.
Materials and Methods: A survey of 233 type 2 diabetic patients recruited from the Diabetes clinic of our hospital 
was carried out. Standard procedures as described in the WHO STEP instrument were used to determine the waist 
circumference, weight, height, and systolic and diastolic blood pressure. Fasting blood glucose and lipid profiles were 
also assessed. Therapeutic goals used to define risk or poor control were values adopted by expert groups such as 
American diabetes association (ADA), National cholesterol education program (NCEP), American association of clinical 
endocrinologist (AACE) and International diabetes federation (IDF).
Results: There were 98 males and 135 females with mean (SD) duration of diabetes mellitus (DM) of 6.7 (6.3) years. 
Suboptimal glycemic, blood pressure control and dyslipidemia were observed in 65.7%, 51.9%, 97.1% of the subjects 
respectively while 60.1% of the subjects were found to be overweight/obese. Comparing the mean indices of risk factors 
with the recommended therapeutic goals, status of control was optimal for HDL-cholesterol, waist circumference and 
triglycerides. All the other risk factors were suboptimal.
Conclusion: Control to goals of cardiovascular risk factors is poor among the patients. There is the need to identify 
and tackle the possible contributing factors so as to reduce the morbidity and mortality in these patients.
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Introduction
Cardiovascular complications contribute to morbidity 
and mortality in people suffering from type 2 diabetes 
mellitus. Diabetes mellitus is counted as a Coronary 
Heart Disease risk equivalent in Adult Treatment Panel 
(ATP) III report.[1] National and international guidelines 
on management of diabetes therefore emphasize control 
of blood pressure, dyslipidemia, and obesity in addition to 
glycemic control.[2,3]
Analysis of causes of death among patients admitted into 
medical wards in urban healthcare centers showed that 
from the fifth decade, cardiovascular diseases (CVD) 
replaced infection as a major cause of death.[4] Diabetes, 
hypertension, dyslipidemia, and obesity are cardiometabolic 
risk factors which frequently coexist to constitute the 
metabolic syndrome which has been described not only in 
Caucasians but also in Nigerians.[5‑7]
Cardiovascular diseases have been identified as the major 
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causes of morbidity and mortality in the developed nations 
of the world for the greater part of the 20th century. This 
trend is increasingly becoming a major health concern 
in the less developed nations of the world which many 
years ago were known to be battling with infectious and 
malnutrition‑related diseases.[8,9] This process was dubbed 
“the epidemiological transition” by Omran and the effect is 
the double burden of communicable and noncommunicable 
diseases that now face sub Saharan Africa.[10]
The study was carried out to evaluate the status of control 
to goals of cardiometabolic risk factors among diabetic 
patients attending the Diabetes clinic of the University 
of Nigeria Teaching Hospital (UNTH), Enugu, a tertiary 
health institution in south‑eastern Nigeria.
Materials and Methods
A cross‑sectional descriptive survey of 233 type 2 diabetic 
patients consecutively recruited from the Diabetes clinic 
of UNTH, Enugu, was carried out. Standard procedures 
as described in the WHO STEPs instrument were used to 
determine the waist circumference, weight, height, and 
systolic and diastolic blood pressure.[11]
Lipid profiles: Total cholesterol was determined using the 
ferric perchlorate method[12] while HDL‑C was determined 
after precipitation of LDL‑C with phosphotungstate and 
magnesium.[13] LDL‑C was calculated from the following 
formula:
LDL‑C=TC – HDL‑C – TG/5.[14]
Triglyceride was measured using the colorimetric enzymatic 
method.[15]
Therapeutic goals used to define poor or optimal control 
were values recommended by different expert groups such as 
American Diabetes Association (ADA), National Cholesterol 
Education Program (NCEP), American Association of 
Clinical Endocrinologists (AACE), and International Diabetes 
Federation (IDF).[1‑3,16] The following therapeutic goals were 




of ≤2.6 mmol/l,  total  cholesterol  (TC)  of ≤5.2 mmol/l, 
triglyceride (TG) of ≤1.7 mmol/l, waist circumference (WC) 
of ≤94 cm for males and 80 cm for females and Body Mass 
Index (BMI) of 25.0–29.9 kg/m2 for classifying overweight and 
≥30.0 kg/m2 for obesity.[2]
Test of significance was done using the one sample t‑test for 
quantitative variables and Chi‑squared test for categorical 
variables. SPSS v 10 was used to run the analysis. A P value 
of ≤0.05 was regarded as significant.
Results
The group consisted of 98 (42.1%) males and 135 (57.9%) 
females with mean (SD) duration of diabetes mellitus 
(DM) of 6.7 (6.3) years. Table 1 shows the summary of the 
descriptive variables for the group.
Males were older and taller while females had higher mean 
indices of generalized and central obesity as determined by 
BMI and waist circumference. Significant gender differences 
were observed for age, height, waist circumference, hip 
circumference, and BMI.
Table 2 compares the mean values of the cardiometabolic 
risk factors with the recommended target goals.
Mean indices of glycemia, blood pressure, obesity, and 
lipid profile were significantly suboptimal except for WC 
(P<0.05) and HDL‑C (P>0.05) (both in the males), and 
insignificant for TG.
Glycemic control was poor in 65.7% of the study subjects, 
of which 61.5% were females and 38.5% males.
Suboptimal blood pressure control was observed in 
121 (51.9%) subjects. A higher proportion (46.6%) of the 
subjects had suboptimal SBP control compared to 32% 
who had suboptimal DBP control. Mean SBP and DBP 
showed significant differences between patients with optimal 
and suboptimal blood pressure control (117.4 ± 11.2 vs. 
Table 1: Summary of clinical characteristics of the 
subjects







Age (years) 55.7 ± 11.7 58.6 ± 13.2 53.3 ± 10.0 0.001
Duration of DM 
(years)
6.7 ± 6.3 7.4 ± 7.2 6.2 ± 5.6 NS
FBG (mmol/l) 10.3 ± 5.4 10.8 ± 0.6 10.0 ± 4.9 NS
SBP (mmHg) 134.6 ± 22.8 133.6 ± 25.2 135.3 ± 20.9 NS
DBP (mmHg) 80.4 ± 21.9 80.1 ± 15.3 80.5 ± 25.7 NS
Weight (kg) 71.2 ± 13.9 69.9 ± 12.7 72.1 ± 14.7 NS
Height (cm) 162.8 ± 10.0 167.1 ± 10.8 159.6 ± 7.9 <0.001
WC (cm) 92.2 ± 12.3 88.8 ± 10.7 94.6 ± 12.8 <0.001
HC (cm) 97.1 ± 11.7 93.6 ± 11.2 99.7 ± 11.4 <0.001
WHR 0.95 ± 0.09 0.95 ± 0.07 .95 ± 0.10 NS
BMI (kg/m2) 27.0 ± 6.2 25.3 ± 24.1 28.3 ± 5.5 <0.001
LDL‑C (mmol/l) 3.12 ± 0.90 3.19 ± 1.20 3.08 ± 0.68 NS











FBG = Fasting blood glucose, WC = Waist circumference, HC = Hip 
circumference, WHR = Waist to hip ratio, SBP = Systolic blood pressure, 
DBP = Diastolic blood pressure, BMI = Body mass index, TC = Total 
cholesterol, LDL‑C = Low density lipoprotein cholesterol, HDL‑C = High 
density lipoprotein cholesterol, TG = Triglyceride. *Test of significant 
difference between the genders, NS = Not significant (P>0.05)
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150.5 ± 19.0 and 72.9 ± 10.9 vs. 87.3 ± 26.8 mmHg 
respectively, P<0.001).
Dyslipidemia was very common among the subjects studied. 
A very high proportion (97.1%) of the subjects had at least 
one suboptimal lipid parameter. This occurred in 60.6% of 
females and 39.4% of males respectively. A total of 79.4% 
had mixed dyslipidemia ranging from 2 to 4 abnormal lipid 
parameters. Abnormal TC, LDL‑C, HDL‑C, and TG were 
noted in 38.2%, 73.5%, 61.8%, and 40% of the subjects 
respectively.
Overweight and obesity were noted in 60.1% of the subjects. 
Greater numbers (84.4%) of female subjects were identified 
to be at increased cardiovascular risk from central obesity 
using the waist circumference. Majority of these females 
(73.3%) had WC>88 cm; a level at which is regarded to 
be severe. Only 35.7% of males were exposed to the same 
risk due to obesity (i.e., WC>94 cm) while 11.2% had WC 
values >102 cm.
Discussion
We have evaluated how well cardiometabolic risk factors 
among our diabetic patients are controlled. The results 
indicated a general poor control to goal of several 
cardiometabolic risk factors among this group of people 
suffering from type 2 diabetes mellitus. People suffering 
from diabetes mellitus are known to be exposed to more 
cardiovascular risk factors than glucose tolerant individuals. 
These risk factors contribute significantly to morbidity and 
mortality.[17] Though the metabolic syndrome has been 
debated on a lot, the best approach to management still 
remains tackling the individual components or cardiovascular 
risk factors identified in any particular individual. No singular 
treatment modality apart from preventive measures can be 
applied to these risk factors. Some risk factors such as age, 
gender, and ethnicity are nonmodifiable; hence focus has 
been on the modifiable factors.
This study showed that cardiometabolic risk factors were 
still suboptimally controlled or poor in a high proportion 
(>50%) of our diabetic patients after a long disease 
duration. This is similar to a multicenter study of elderly 
diabetic patients which revealed that >80% of treated 
patients with diabetes at baseline were not achieving fasting 
blood glucose goals of ≤6.7 mmol/l (120 mg/dl) after 7 years 
of follow‑up.[18] Our study showed suboptimal glycemic 
control in about 65% of the subjects. We may have recorded 
a slightly lower proportion compared to that of Smith et al.[18] 
because our subjects were younger in age. Younger subjects 
may be better motivated to adhere with follow‑up schedules 
and drug intake than elderly patients. Ageing is likely to 
reduce the quality of life (QOL) of individuals which in 
turn may lead to depression especially on a background of 
chronic ailments many of which remain without cure for 
now such as diabetes mellitus. The impact of reduced QOL 
may be seen in its effect on the degree of adherence with 
therapeutic measures geared toward achieving control to 
goals. This study however did not consider the effect of 
disease duration and duration of follow‑up of our patients. 
The use of higher therapeutic goal of 7.2 mmol/l in this 
study most likely would have contributed to some of the 
differences too. The difference in proportion may have 
been widened if a lower threshold was used. On the other 
hand, age differences may not entirely be responsible. In 
Trinidad, Ezenwaka and Offiah[19] noted that younger 
patients with type 2 diabetes had poorer metabolic control 
and higher prevalence rates of cardiovascular disease risk 
factors than the elderly patients. This greater risk was 
not independent of gender and ethnicity. Generally, poor 
health seeking behaviors may also contribute to poor 
control among patients. This health seeking behaviors 
are characterized by lack of understanding of their role in 
their disease management, poor affordability (poverty) and 
accessibility of quality healthcare services and lack of use of 
effective medications/health care facilities.[20‑22] Difficulties 
with readjustment of lifestyles which form the foundation 
for successful management of non communicable diseases 
may also play some roles.[23]
Observations on glycemic control in this study should be 
interpreted with caution as the fasting blood glucose (FBG) 
Table 2: Mean values of cardiometabolic risk factors 
compared to the recommended therapeutic goals











FBG (mmol/l) suboptimal 10.3 7.2 <0.001
Blood pressure 
control
SBP (mmHg) suboptimal 134.6 ≤130 0.002
DBP (mmHg) Suboptimal 80.4 ≤80 >0.05
Obesity control
WC (cm)
M Optimal 88.8 ≤94 <0.001
F Suboptimal 94.6 ≤80 <0.001
BMI (kg/m2) Suboptimal 27.0 ≤24.9 <0.001
Lipid profile
LDL‑C (mmol/l) Suboptimal 3.12 <2.6 0.002
TC (mmol/l) Suboptimal 5.30 <5.2 >0.05
HDL‑C (mmol/l)
M Optimal 1.17 >1.15 >0.05
F Suboptimal 1.25 >1.4 >0.05
TG (mmol/l) Optimal 1.56 <1.7 >0.05
*Status of control was based on the mean observed value. FBG = Fasting 
blood glucose, WC = Waist circumference, HC = Hip circumference, 
WHR = Waist to hip ratio, SBP = Systolic blood pressure, DBP = Diastolic 
blood pressure, BMI = Body mass index, TC = Total cholesterol, 
LDL‑C = Low density lipoprotein cholesterol, HDL‑C = High density 
lipoprotein cholesterol, TG = Triglyceride. M = Males, F = Females
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is not quite representative of long term glycemic control 
which is better assessed by performing glycated hemoglobin 
(HbA1c). This was not available in our center when the 
study was carried out.
Conclusion
Cardiometabolic risk factors control was poor among our 
diabetic patients. The presence of diabetes mellitus is already 
a serious problem with its attendant complications. In the 
presence of other comorbidities, exposure to mortality from 
cardiovascular events is heightened. Greater proactive 
measures are therefore still required from care providers in 
other to improve the status of control and in effect, reduce 
the likely burden of cardiovascular morbidity and mortality 
among our patients.
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